NASDAQ: HOTH
Hoth Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for HOTH

Based on 2 analysts offering 12 month price targets for Hoth Therapeutics Inc

Min Forecast
$4.00+205.34%
Avg Forecast
$4.50+243.51%
Max Forecast
$5.00+281.68%

Should I buy or sell HOTH stock?

Based on 2 analysts offering ratings for Hoth Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HOTH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HOTH as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HOTH stock forecasts and price targets.

HOTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-12
lockedlocked$00.00+00.00%2025-01-23

1 of 1

Forecast return on equity

Is HOTH forecast to generate an efficient return?

Company
N/A
Industry
82.98%
Market
67.3%

Forecast return on assets

Is HOTH forecast to generate an efficient return on assets?

Company
N/A
Industry
22.28%

HOTH earnings per share forecast

What is HOTH's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.97

HOTH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HOTH$1.31$4.50+243.51%Strong Buy
MRKR$1.52$10.25+574.34%Strong Buy
ASBP$0.35N/AN/A
CLRB$0.38N/AN/A
LEXX$1.01$7.00+593.07%Buy

Hoth Therapeutics Stock Forecast FAQ

Is Hoth Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: HOTH) stock is to Strong Buy HOTH stock.

Out of 2 analysts, 1 (50%) are recommending HOTH as a Strong Buy, 1 (50%) are recommending HOTH as a Buy, 0 (0%) are recommending HOTH as a Hold, 0 (0%) are recommending HOTH as a Sell, and 0 (0%) are recommending HOTH as a Strong Sell.

If you're new to stock investing, here's how to buy Hoth Therapeutics stock.

What is HOTH's earnings growth forecast for 2025-2025?

(NASDAQ: HOTH) Hoth Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.72%.

Hoth Therapeutics's earnings in 2025 is -$9,623,353.

In 2025, HOTH is forecast to generate -$12,812,648 in earnings, with the lowest earnings forecast at -$12,812,648 and the highest earnings forecast at -$12,812,648.

What is HOTH's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: HOTH) forecast ROE is N/A, which is considered weak.

What is HOTH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HOTH price target, the average HOTH price target is $4.50, with the highest HOTH stock price forecast at $5.00 and the lowest HOTH stock price forecast at $4.00.

On average, Wall Street analysts predict that Hoth Therapeutics's share price could reach $4.50 by Jun 12, 2026. The average Hoth Therapeutics stock price prediction forecasts a potential upside of 243.51% from the current HOTH share price of $1.31.

What is HOTH's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: HOTH) Hoth Therapeutics's current Earnings Per Share (EPS) is -$1.14. In 2025, HOTH's EPS is forecast to hit -$0.97 (min: -$0.97, max: -$0.97).

What is HOTH's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: HOTH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.28%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.